Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Insulin Resistance & Diabetes

Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome

T. Kyaw Tun; A. McGowan; N. Phelan; N. Correia; G. Boran; A. L. O'Connor; H. M. Roche; J. Gibney Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome Int J Endocrinol
Cholesterol Insulin Resistance & Diabetes PCOS

Higher circulating bile acid concentrations in obese patients with type 2 diabetes

R. P. Vincent; S. Omar; S. Ghozlan; D. R. Taylor; G. Cross; R. A. Sherwood; L. Fandriks; T. Olbers; M. Werling; J. Alaghband-Zadeh; C. W. le Roux Higher circulating bile acid concentrations in obese patients with type 2 diabetes Annals of Clinical Biochemistry
Insulin Resistance & Diabetes

Type 2 diabetes: multimodal treatment of a complex disease

D. J. Pournaras; C. W. le Roux Type 2 diabetes: multimodal treatment of a complex disease Lancet
Insulin Resistance & Diabetes

Review of multimodal treatment for type 2 diabetes: combining metabolic surgery and pharmacotherapy

A. Sudlow; C. W. le Roux; D. J. Pournaras Review of multimodal treatment for type 2 diabetes: combining metabolic surgery and pharmacotherapy Ther Adv Endocrinol Metab
Insulin Resistance & Diabetes

A prospective randomized controlled trial of lifestyle intervention on quality of life and cardiovascular risk score in patients with obesity and type 2 diabetes

A. Tuthill; A. Quinn; D. McColgan; M. McKenna; D. O'Shea; T. J. McKenna A prospective randomized controlled trial of lifestyle intervention on quality of life and cardiovascular risk score in patients with obesity and type 2 diabetes Diabetes, obesity & metabolism
Insulin Resistance & Diabetes

Can we predict diabetes remission after weight-loss surgery?

D. J. Pournaras; C. W. le Roux Can we predict diabetes remission after weight-loss surgery? Lancet Diabetes Endocrinol
Insulin Resistance & Diabetes

Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analyses

E. R. McGlone; I. Carey; V. Veličković; P. Chana; K. Mahawar; R. L. Batterham; J. Hopkins; P. Walton; R. Kinsman; J. Byrne; S. Somers; D. Kerrigan; V. Menon; C. Borg; A. Ahmed; B. Sgromo; C. Cheruvu; G. Bano; C. Leonard; H. Thom; C. W. le Roux; M. Reddy; Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analyses PLoS Med
Insulin Resistance & Diabetes

Type 2 diabetes mellitus and microvascular complications 1 year after Roux-en-Y gastric bypass: a case–control study

A. D. Miras; L. L. Chuah; N. Khalil; A. Nicotra; A. Vusirikala; N. Baqai; C. Graham; S. Ravindra; G. Lascaratos; N. Oliver; C. W. le Roux Type 2 diabetes mellitus and microvascular complications 1 year after Roux-en-Y gastric bypass: a case–control study Diabetologia
Insulin Resistance & Diabetes

Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses

E. Molina-Montes; C. Coscia; P. Gómez-Rubio; A. Fernández; R. Boenink; M. Rava; M. Márquez; X. Molero; M. Löhr; L. Sharp; C. W. Michalski; A. Farré; J. Perea; M. O'Rorke; W. Greenhalf; M. Iglesias; A. Tardón; T. M. Gress; V. M. Barberá; T. Crnogorac-Jurce Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses Gut
Insulin Resistance & Diabetes

Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation

I. Lingvay; P. Sumithran; R. V. Cohen; C. W. le Roux Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation Lancet
Insulin Resistance & Diabetes

Older posts

Newer posts

← Previous Page1 … Page8 Page9 Page10 … Page32 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Menu

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2024 ASOI